RE: Proof of concept9 Dec 2020 09:54
Eventually, I would expect Alastair to get something to market. To be honest, even I expected BAMS to be on the market by now. If and when something comes to market, the price should go up. The point is, this stock is not the golden goose people made it out to be. My analysis dating back to May has been proven correct. I simply stated that given the body of evidence, it seemed unlikely Alastair was going to deliver anything he promised in the timescale he set. I also stated the market would be rife with competition by October, I was right about that. I also said the vaccine would be available this year and everyone said I was crazy, but I was also right about that.
Bottom line, Alastair can still potentially deliver something, and there is room for improvement from the current SP level. He is dreadfully incompetent among many other things, so there's no point getting too optimistic though. Has the boat that would have carried shareholders to the riches being touted by Myles et al been missed now? Absolutely it has. I've been proved right, and there's nothing that can undo that now.
The company failed to deliver when it said it would, and has missed the big boat end of. As the months drag on, the company will simply be playing for peanuts. Will it get hyped in the future, almost certainly. Is there room to trade? possibly.
Conclusion: 300m market cap and no product on the market still. Potential for the covid products is getting less favorable with every hour that passes. Cancer treatment is no further ahead than it was 12 months ago and only tested on a few mice. They have funding, that's one good thing. IMO market cap should be around 100m now if you remove the hype.